Works matching IS 23988835 AND DT 2019 AND VI 2 AND IP 3

Results: 6
    1

    Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE‐I Part II).

    Published in:
    Health Science Reports, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/hsr2.92
    By:
    • Asselah, Tarik;
    • Alami, Negar Niki;
    • Moreno, Christophe;
    • Pol, Stanislas;
    • Karatapanis, Stylianos;
    • Gschwantler, Michael;
    • Horsmans, Yves;
    • Elefsiniotis, Ioannis;
    • Larrey, Dominique;
    • Ferrari, Carlo;
    • Rizzetto, Mario;
    • Orlandini, Alessandra;
    • Calleja, Jose Luis;
    • Bruno, Savino;
    • Schnell, Gretja;
    • Qaqish, Roula;
    • Redman, Rebecca;
    • Pilot‐Matias, Tami;
    • Kopecky‐Bromberg, Sarah;
    • Yu, Yao
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    Health Science Reports, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/hsr2.64
    Publication type:
    Article
    3
    4
    5
    6